DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 199 filers reported holding DENALI THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,738,611 | -30.1% | 1,150,684 | 0.0% | 1.21% | -34.1% |
| Q2 2023 | $33,956,685 | +45.2% | 1,150,684 | +13.4% | 1.84% | +98.5% |
| Q1 2023 | $23,378,319 | -17.2% | 1,014,684 | 0.0% | 0.92% | -25.9% |
| Q4 2022 | $28,218,362 | -9.4% | 1,014,684 | 0.0% | 1.25% | -35.0% |
| Q3 2022 | $31,141,000 | +4.3% | 1,014,684 | 0.0% | 1.92% | +12.6% |
| Q2 2022 | $29,862,000 | -8.5% | 1,014,684 | 0.0% | 1.71% | +14.6% |
| Q1 2022 | $32,642,000 | +118.4% | 1,014,684 | +202.7% | 1.49% | +95.3% |
| Q4 2021 | $14,949,000 | – | 335,184 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $298,165,000 | 48.02% |
| Bratton Capital Management, L.P. | 953,035 | $14,600,000 | 28.53% |
| Flagship Pioneering Inc. | 8,005,747 | $122,648,000 | 6.71% |
| Casdin Capital, LLC | 650,000 | $9,958,000,000 | 1.03% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $67,568,000 | 0.50% |
| MARK ASSET MANAGEMENT LP | 68,864 | $1,055,000 | 0.26% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 22,507 | $345,000 | 0.26% |
| Artal Group S.A. | 400,000 | $6,128,000 | 0.25% |
| PIER 88 INVESTMENT PARTNERS LLC | 40,610 | $622,000 | 0.24% |
| HAMILTON LANE ADVISORS LLC | 30,948 | $474,000 | 0.20% |